scholarly article | Q13442814 |
P356 | DOI | 10.1016/0361-9230(94)00243-T |
P698 | PubMed publication ID | 7757496 |
P2093 | author name string | X Wang | |
G Z Feuerstein | |||
T L Yue | |||
F C Barone | |||
R F White | |||
P433 | issue | 6 | |
P921 | main subject | cerebral infarction | Q1209150 |
P304 | page(s) | 607-609 | |
P577 | publication date | 1995-01-01 | |
P1433 | published in | Brain Research Bulletin | Q4955784 |
P1476 | title | Transforming growth factor-beta 1 exhibits delayed gene expression following focal cerebral ischemia | |
P478 | volume | 36 |
Q35487879 | Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy |
Q21129284 | Astrocytes as a source for extracellular matrix molecules and cytokines |
Q48156248 | Biphasic expression of TGF-beta1 mRNA in the rat brain following permanent occlusion of the middle cerebral artery |
Q73138933 | Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease |
Q37602716 | Cerebral ischemic damage in diabetes: an inflammatory perspective |
Q31006509 | Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation. |
Q48105299 | Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. |
Q41712794 | Delayed expression of osteopontin after focal stroke in the rat. |
Q48290859 | Expression of nitric oxide synthase-2 in glia associated with CNS pathology. |
Q37149831 | Human Recombinant Hyaluronidase Injections For Upper Limb Muscle Stiffness in Individuals With Cerebral Injury: A Case Series. |
Q34039076 | In the hypoxic central nervous system, endothelial cell proliferation is followed by astrocyte activation, proliferation, and increased expression of the alpha 6 beta 4 integrin and dystroglycan |
Q37286371 | Microglia are the major source of TNF-α and TGF-β1 in postnatal glial cultures; regulation by cytokines, lipopolysaccharide, and vitronectin |
Q24796385 | Modelling neuroinflammatory phenotypes in vivo |
Q34238350 | Modulation of the postischemic immune response to improve stroke outcome. |
Q34727139 | Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here |
Q35741374 | Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. |
Q28393830 | Reactive astrocytes and therapeutic potential in focal ischemic stroke |
Q37794398 | Reactive astrocytes as therapeutic targets for CNS disorders |
Q47913171 | Reduction of cortical infarction and impairment of apoptosis in NGF-transgenic mice subjected to permanent focal ischemia |
Q35672543 | Smad3-dependent signaling underlies the TGF-β1-mediated enhancement in astrocytic iNOS expression |
Q47992438 | TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases |
Q77227273 | TGF-beta receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy |
Q48441907 | TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2. |
Q30479052 | TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. |
Q38172986 | The use of microRNAs to modulate redox and immune response to stroke |
Q34441994 | Time course, distribution and cell types of induction of transforming growth factor betas following middle cerebral artery occlusion in the rat brain |
Q44590863 | Up-Regulation of Secretory Leukocyte Protease Inhibitor (SLPI) in the Brain after Ischemic Stroke: Adenoviral Expression of SLPI Protects Brain from Ischemic Injury |
Search more.